Gennex Laboratories Ltd vs Glenmark Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 12, 2026

Key Highlights

The Latest Trading Price of Gennex Laboratories Ltd is ₹ 10.04 as of 11 Jun 15:30 . The P/E Ratio of Gennex Laboratories Ltd changed from 12.2 on March 2021 to 15.1 on March 2025 . This represents a CAGR of 4.36% over 5 yearsThe P/E Ratio of Glenmark Pharmaceuticals Ltd changed from 13.5 on March 2021 to 41.5 on March 2025 . This represents a CAGR of 25.18% over 5 years The Market Cap of Gennex Laboratories Ltd changed from ₹ 49.46 crore on March 2021 to ₹ 274.07 crore on March 2025 . This represents a CAGR of 40.84% over 5 yearsThe Market Cap of Glenmark Pharmaceuticals Ltd changed from ₹ 13108 crore on March 2021 to ₹ 43458 crore on March 2025 . This represents a CAGR of 27.09% over 5 years The revenue of Gennex Laboratories Ltd for the Mar '26 is ₹ 62.27 crore as compare to the Dec '25 revenue of ₹ 42.96 crore. This represent the growth of 44.95% The revenue of Glenmark Pharmaceuticals Ltd for the Mar '26 is ₹ 3959 crore as compare to the Dec '25 revenue of ₹ 3945 crore. This represent the growth of 0.37% The ebitda of Gennex Laboratories Ltd for the Mar '26 is ₹ 6.9 crore as compare to the Dec '25 ebitda of ₹ 8.27 crore. This represent the decline of -16.57% The ebitda of Glenmark Pharmaceuticals Ltd for the Mar '26 is ₹ 578.28 crore as compare to the Dec '25 ebitda of ₹ 729.88 crore. This represent the decline of -20.77% The net profit of Gennex Laboratories Ltd changed from ₹ 4.66 crore to ₹ 4.46 crore over 8 quarters. This represents a CAGR of -2.17% The net profit of Glenmark Pharmaceuticals Ltd changed from ₹ 340.24 crore to ₹ 301.32 crore over 8 quarters. This represents a CAGR of -5.89% The Dividend Payout of Gennex Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Glenmark Pharmaceuticals Ltd changed from 4.28 % on March 2021 to 4.38 % on March 2025 . This represents a CAGR of 0.46% over 5 years .

About Gennex Laboratories Ltd

Gennex Laboratories Limited, formerly known as Prudential Pharmaceuticals Limited was incorporated on June 25, 1985.
The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007. The Company is in the business of Manufacturing of Bulk Drugs, Intermediates and Biotech Products.
The Company has over the years added more capacity and infrastructure by way of an additional production block and equipment to the plant to handle more products and tonnages.
The Company is having a professionally managed team at every stage of its operations. Apart from these, Gennex is among the leading Vertically Integrated' pharmaceutical companies in India and has a robust product portfolio spread over major product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal.

About Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977.
The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets.
The Company's research and development facilities are located at Mahape, Sinnar and Taloja and manufacturing facilities are located at Nasik, Colvale, Baddi, Nalagarh, Sikkim, Indore and Aurangabad in India. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
Its branded generics business has a significant presence in markets across emerging economies including India.

FAQs for the comparison of Gennex Laboratories Ltd and Glenmark Pharmaceuticals Ltd

Which company has a larger market capitalization, Gennex Laboratories Ltd or Glenmark Pharmaceuticals Ltd?

Market cap of Gennex Laboratories Ltd is 243 Cr while Market cap of Glenmark Pharmaceuticals Ltd is 60,513 Cr

What are the key factors driving the stock performance of Gennex Laboratories Ltd and Glenmark Pharmaceuticals Ltd?

The stock performance of Gennex Laboratories Ltd and Glenmark Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gennex Laboratories Ltd and Glenmark Pharmaceuticals Ltd?

As of June 12, 2026, the Gennex Laboratories Ltd stock price is INR ₹10.04. On the other hand, Glenmark Pharmaceuticals Ltd stock price is INR ₹2144.35.

How do dividend payouts of Gennex Laboratories Ltd and Glenmark Pharmaceuticals Ltd compare?

To compare the dividend payouts of Gennex Laboratories Ltd and Glenmark Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.